Table 1.

Patient information materials provided by centres and received by patients

Type of information	Centres		Patients
	n	%	n	%
Disease-specific information	82/147	55·8*	352/509	69·2
Patient advocacy groups	98/147	66·7†	NR
Nutrition	79/147	53·7†	146/493	29·6
Sport/physical activity	69/147	46·9†	85/491	17·3
Other	12/147	8·2†	34/441	7·7

NR, not reported.

^*Urologists were asked: In your opinion, what methods could improve patient compliance with the treatment? (multiple answers are permitted)

• More time for explanations by reducing other time-consuming obligations

• Printed material/brochures to inform patients about the disease and the benefits and possible risks of treatment

• Material on the Internet to inform patients about the disease and the benefits and possible risks of treatment

• Inclusion of family members

• Public information campaign about prostatic carcinoma and its treatment

• Greater support for patient self-help organisations

• Frequent testing of the testosterone level as an easily communicable efficacy criterion

• Frequent testing of the PSA level as an easily communicable efficacy criterion

• Patient-friendly pharmaceutical form of hormone therapy

• Other: _________________________________

^†Urologists were asked: What concomitant measures do you suggest to your patients who have prostatic carcinoma?

○ Nutritional advice

○ Sports groups

○ Patient self-help organisations

Other: _________________________________